Back
Home » Health
  •  
    Filmi Bollywood
    • Kriti Sanon Sports Baby Bump In Leaked First Look From Sets Of Mimi
    • Malaika Arora Recalls Struggling Days, Says 'Rejections Never Let Me Down'
    • Coronavirus Outbreak: Indian Stuck On Diamond Princess Ship In Japan Sings Arijit Singh’s Song
    • Anubhav Sinha And Taapsee Pannu Are All Elated After Thappad’s First Screening In Delhi
    • Arshad Warsi Joins Cast Of Bhumi Pednekar's Horror Thriller Durgavati
    • Atrangi Re: Sara Ali Khan To Romance Dhanush And Akshay Kumar In Double Role?
    • Saif Ali Khan: Amrita Singh Was Never Compelled To Convert To Islam [Flashback]
    • Hrithik Roshan Is Impressed With Tanhaji; Showers Praises On Kajol, Ajay Devgn And Saif Ali Khan
    • Rajkummar Rao, Kriti Sanon To Adopt Dimple Kapadia And Paresh Rawal As Parents In Their Next Film
    • Sonam Kapoor Remembers Playing Neerja On Film’s 4th Anniversary; Says It Was An Honour
    • Guilty Filmmaker Ruchi Narain Felt Angry When Male Actors Refused To Work With Her!
    • Dabboo Ratnani 2020 Calendar: Bhumi Pednekar, Vicky Kaushal And Others Have Got Us Drooling!
    • Sonam Kapoor To Star In A Sujoy Ghosh Film Titled Blind?
    • Is Taapsee Pannu’s Thappad A Male-bashing Film? Here’s What Actor Pavail Gulati Has To Say
Study Reveals A New Drug May Help Treat Brain Tumours
Boldsky | 12th Aug, 2019 03:23 PM

The research team led by Dr Richard Hill at the Brain Tumour Research Centre at University of Portsmouth (in collaboration with the University of Algarve (Portugal), the University of Liverpool (UK) and Innovate Pharmaceuticals) examined the possible impact of IP1867B in treating a brain tumour, which kills thousands of people every year.

IP1867B, the potential brain cancer treatment drug may help in shrinking brain tumours. The research study was conducted by applying the drug to existing (cancer) treatments and IP1867B was effective in boosting the potency of the treatments and renewed sensitivity to some treatments.

Also read: Artificial Intelligence Can Help Decode Epileptic Brains, Affirms Research

IP1867B can be termed as a revolutionary finding considering the limited success rates of cancer treatments. The limitation of the treatments is due to several factors such as the tumour's ability to develop resistance and hide from the treatment, lack of clinical effectiveness of the treatment, severe side effects and the inability of the medicine to penetrate through the blood-brain barrier. Consequently, during the study, IP1867B was successful at bypassing such factors .

In the study, 'IP1867B suppresses the insulin-like growth factor 1 receptor (IGF1R)...adult high-grade gliomas' published in the journal of Cancer Letters suggested that IP1867B - a combination of aspirin, triacetin and saccharin, worked towards reducing the size of adult high-grade glioma brain tumours in a mouse model. Along with that, the drug also helped in reducing the gastrointestinal tract problems caused due to the consumption of conventional aspirin tablets.

Therefore, the researchers asserted that IP1867B could be effective against one of the most aggressive forms of human brain cancer, glioblastoma (GBM). According to Dr Hill, the researcher team head, "To produce a completely new drug takes many years and is very expensive. By focusing our efforts on testing novel formulation techniques, we can move closer to treatment more quickly than would otherwise be possible."

He continued, "We will continue to urgently investigate which drugs will combine most effectively and safely with IP1867B, to improve these results even further and reduce the need for long-term use. There is still much work to be done, but many reasons to be excited about future studies."

The researcher tested various combinations of drugs to understand the most effective treatment, which also included separately testing the three key components of IP1867B. It was found that IP1867B was more effective than some of the chemotherapeutics being used in treatments.

The drug, IP1867B reduced the action of Epidermal Growth Factor Receptor (EGFR) and blocked the Insulin-like Growth Factor 1 pathway. This, in turn, helped reduce the tumour's ability to acquire resistance to the EGFR inhibitors. IP1867B can affect multiple targets, which in turn helps in highlighting the tumour and reverse acquired resistance .

Also read: Medication To Suppress HIV Infection Discovered, Researchers Assert

Dr James Stuart, Medical Director at Innovate Pharmaceuticals asserted, "The next step is to take IP1867B into 'first in human' trial. Innovate are actively driving this next stage of development."

   
 
Health and Life
  • 15 Indian Spices And Their Amazing Health Benefits
  • 10 Natural Ways To Prevent Mosquito Bites
  • Ways To Include Chicken Breast In Your Diet And Its Health Benefits
    • Having A Nosebleed? Here's A Guide On How To Stop And Prevent It
    • 10 Fruits To Avoid For Diabetes
    • List Of Diseases Caused By Smoking
      • 17 Foods To Eat And Avoid Before Travelling
      • Vitamin K Deficiency: Causes, Symptoms, Diagnosis, Treatment And Prevention
      • 11 Reasons Why You Should Be Drinking Potato Juice
        • 7 Different Ways To Eat Honey For Weight Loss
        • Ways To Use Mint (Pudina) Leaves For Weight Loss
        • 10 Foods To Combat Stomach Gas
          • 8 Morning Habits That Can Cause Weight Gain
          • 7 Risks Associated With Iron Overload
          • 9 Science-backed Benefits Of Intermittent Fasting
            • Top 21 Foods To Build Muscle
            • 10 Healthy Foods To Combat Period Acne
            • 10 Foods To Flush The Nicotine Out Of The Body
              • 7 Benefits Of Eating Poha For Breakfast
              • 10 High Fibre Vegetables To Lose Weight Easily
              • 10 Best Foods With Good Fat For Weight Loss